News Release

Investigation: Problems in clinical trial reporting continue amid lax federal enforcement

Peer-Reviewed Publication

American Association for the Advancement of Science (AAAS)

Companies, universities, and other institutions that conduct clinical trials are required to record the results of most of them in a federal database, so that doctors and patients can see whether new treatments are safe and effective. But a Science investigation has found that many persist in not reporting those results, and FDA and NIH are doing little to nothing to enforce the reporting requirement despite recent promises to the contrary. While many pharma companies have improved their reporting of trial results over the last few years, a large number of universities and academic medical centers continue to have bad records. Ironically, NIH itself is part of the problem--its top institutes for clinical trials have a poor record of reporting results of those trials for which they are responsible. Science checked all 4,768 trials whose results have come due under legal requirements finalized by NIH and FDA three years ago. Overall, sponsors violated the reporting law more than 55% of the time. Yet FDA has never fined a trial sponsor for non-compliance and NIH has never publicly named or withdrawn a grant from violators, although such actions were vowed in 2016 when's requirements were clarified.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.